Eve Wellness Empowers Women with Advanced AI Technology for Early Breast Screenings

By: PRLog

SAN FRANCISCO - June 20, 2023 - PRLog -- Eve Wellness, a leading healthcare provider in San Francisco, is transforming breast cancer detection by empowering women with state-of-the-art AI technology for early screenings. By integrating AI with Ultrasound screening with the output read by a leading breast surgeon, Eve Wellness aims to enhance the detection of breast cancer, particularly in women with dense breast tissue, which can pose challenges for traditional mammography.

San Francisco now boasts an innovative clinic that offers the combined benefits of FDA-approved Breast Ultrasound and FDA-approved AI. Extensive clinical trials have revealed that when used alongside the GE ABUS, the QView CAD AI Assistant can identify an impressive 35.7% more cancer than ABUS alone.

Eve Wellness is committed to providing women access to cutting-edge breast screening technology by integrating AI capabilities with the GE ABUS Ultrasound machine. This comprehensive ultrasound examination of the entire breast yields highly accurate results without exposing patients to radiation or discomfort. The clinic offers convenient same-day appointments without needing a doctor's referral, ensuring accessibility for all. Prompt physician-read results are delivered within 24 hours, offering women peace of mind.

"At Eve Wellness, our primary focus is empowering women to take proactive steps in managing their breast health and undergoing screenings at an early stage," emphasized Brendan Foley, Chief Marketing Officer at Eve Wellness. "The recent shift in screening age signifies a significant change in our fight against this disease. Lowering the screening age to 40 underscores the potential for more proactive measures, particularly for the substantial demographic of women with dense breast tissue. Ultrasound screening is a leading screening solution for women with dense breast tissue and deserves serious consideration for women wanting to be proactive about their health."

Medical Director Dr. Ian Grady, MD, a highly experienced breast surgeon specializing in breast cancer detection and treatment for over 35 years, leads the expert team at Eve Wellness. Dr. Grady's expertise and unwavering dedication ensure that patients at Eve Wellness receive the highest level of care and attention.

Recent guidelines from experts and an enlightening report by the Los Angeles Times highlighted the importance of early breast screenings with the latest technology. Women are advised not to wait until age 50 to undergo screening and are encouraged to consider the safety and effectiveness of breast ultrasounds. At Eve Wellness, women can begin screening as early as their 20s. As The New York Times emphasized, AI represents a significant advancement in detection, particularly when analyzing thousands of ultrasound images. The combination of GE ABUS and QVCad AI distinguishes Eve Wellness from other facilities in San Francisco.

Breast cancer remains one of the most prevalent forms of cancer among women in the United States, with over 43,000 annual deaths nationwide. Regular screenings are crucial for early detection and pivotal in successful treatment. Notably, nearly half of all women have dense breast tissue, which presents challenges in cancer detection with standard mammography.  However, through the use of breast ultrasound screenings, cancer can be detected much better in dense breast tissue..

For more information about Eve Wellness and its state-of-the-art breast screening services, please visit www.myevewellness.com.

Media Contact
Brendan Foley
CMO - Eve Wellness
info@myevewellness.com

Photos: (Click photo to enlarge)

Eve Wellness Logo

Read Full Story - Eve Wellness Empowers Women with Advanced AI Technology for Early Breast Screenings | More news from this source

Press release distribution by PRLog
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.